Caris Life Sciences (CAI) Interest Expenses (2024 - 2026)

Caris Life Sciences' Interest Expenses history runs 3 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• In Q1 2026, Interest Expenses changed 0.21% year-over-year to $12.8 million; the TTM figure through Mar 2026 stood at $56.9 million (up 6.28% YoY), while the FY2025 annual figure was $56.9 million, up 13.65% from the prior year.
• Interest Expenses was $12.8 million for Q1 2026 at Caris Life Sciences, up from $11.4 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $19.2 million in Q2 2025 to a low of $11.4 million in Q4 2025.
• Historically, Interest Expenses has averaged $13.8 million across 3 years, with a median of $13.4 million in 2024.
• Biggest YoY gain for Interest Expenses was 40.47% in 2025; the steepest drop was 14.37% in 2025.
• A 3-year view of Interest Expenses shows it stood at $13.3 million in 2024, then declined by 14.37% to $11.4 million in 2025, then advanced by 12.79% to $12.8 million in 2026.
• The last three Interest Expenses figures came in at $12.8 million (Q1 2026), $11.4 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.